MEDPLUS Medplus Health Services Q3 FY26 results (Oct–Dec 2025) and concall
Medplus Health reported a strong Q3 FY26 with consolidated revenue of ₹18,061 million and healthy growth in pharmacy and diagnostic segments. The company achieved a net addition of 182 stores, contributing to a 10%+ SSSG driven by strategic incentive structure changes and improved availability. While a one-off charge related to new Labour Codes impacted EBITDA, management remains optimistic about margin trajectory and continued store expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 26.0%, net profit up 88.9% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 156 | 177 | 202 | 184 | 206 +32% | 223 +26% |
| EBITDA | 17 | 19 | 24 | 24 | 27 +59% | 29 +53% |
| Net profit | 8 | 9 | 14 | 14 | 16 +100% | 17 +89% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
